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A B S T R A C T
Interpersonal difficulties are common among veterans with posttraumatic stress disorder (PTSD) and are asso-
ciated with poorer treatment response. Treatment outcomes for PTSD, including relationship functioning, im-
prove when partners are included and engaged in the therapy process. Cognitive-behavioral conjoint therapy for
PTSD (CBCT) is a manualized 15-session intervention designed for couples in which one partner has PTSD. CBCT
was developed specifically to treat PTSD, engage a partner in treatment, and improve interpersonal functioning.
However, recent research suggests that an abbreviated CBCT protocol may lead to sufficient gains in PTSD and
relationship functioning, and yield lower dropout rates. Likewise, many veterans report a preference for re-
ceiving psychological treatments through clinical videoteleconferencing (CVT) rather than traditional face-to-
face modalities that require travel to VA clinics. This manuscript describes the development and implementation
of a novel randomized controlled trial (RCT) that examines the efficacy of an abbreviated 8-session version of
CBCT (“brief CBCT,” or B-CBCT), and compares the efficacy of this intervention delivered via CVT to traditional
in-person platforms. Veterans and their partners were randomized to receive B-CBCT in a traditional Veterans
Affairs office-based setting (B-CBCT-Office), CBCT through CVT with the veteran and partner at home (B-CBCT-
Home), or an in office-delivered, couple-based psychoeducation control condition (PTSD Family Education).
This study is the first RCT designed to investigate the delivery of B-CBCT specifically to veterans with PTSD and
their partners, as well as to examine the delivery of B-CBCT over a CVT modality; findings could increase access
to care to veterans with PTSD and their partners.
1. Introduction
Approximately 5%–20% of recent veterans have posttraumatic
stress disorder (PTSD); the lifetime prevalence among Vietnam era
veterans is 17% [1]. PTSD is associated with other psychological pro-
blems [2], unemployment [3], and suicidality [4]. Relationship pro-
blems associated with PTSD include poor intimate relationship adjust-
ment, parenting problems, intrafamilial violence, and separation/
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divorce [5–7]. Somatic symptoms, anxiety, insomnia, depression, and
low partner self-esteem are also associated with poorer relationship
functioning [8].
PTSD treatment outcomes are enhanced when both partners engage
in therapy [8,9]. Cognitive-behavioral conjoint therapy for PTSD (CBCT
[10]; is a manualized 15-session treatment for couples in which one
partner has PTSD, and simultaneously reduces PTSD symptoms and
enhances relationship functioning. Preliminary trials of CBCT support
its efficacy in veteran and community samples [11].
Couples often encounter obstacles to receiving care, including
agency-level barriers (e.g., few rural providers [12]; client-level bar-
riers (e.g., transportation, child care, fear of stigmatization), and PTSD-
specific obstacles (e.g., avoidance; [13–15]. Clinical videotelec-
onferencing (CVT) provides a safe, effective, and cost-efficient way of
delivering evidence-based treatments remotely (e.g., Refs. [16–18].
Studies of CVT delivered clinic-to-clinic demonstrate reductions in
some barriers to care. Extending CVT to include home-based service
delivery, where patients remain at home and connect to clinicians at
their office, could address remaining impediments. However, more re-
search is needed on the effectiveness of home-based CVT for couples
[19]. This study will address this gap.
In the pilot phase of this study, two-thirds of couples dropped out
around session seven. This is consistent with data from the CBCT dis-
semination within the Veteran's Health Administration (S.Glynn, per-
sonal communication, July 2018). Moreover, studies of the first eight
sessions of CBCT yielded significant pre-to post-treatment reductions in
PTSD with large effect sizes (g= 1.07; [20,21]. A rigorous evaluation of
the efficacy, acceptability, and feasibility of a briefer version of CBCT
(B-CBCT) for veteran couples is needed to establish its efficacy and
effectiveness.
The primary aim of this 4-year RCT is to evaluate the superiority of
an 8-session version of CBCT, B-CBCT, delivered via two modalities (B-
CBCT-OB and B-CBCT-HB) compared with PFE (Fig. 1). The primary
hypothesis is that both CBCT modalities will yield significantly greater
reductions in PTSD symptoms, couples' relationship distress, and
functional impairment when compared with PFE. The CBCT modalities
are compared to the control condition on a range of secondary out-
comes, including PTSD diagnosis, patient-rated PTSD symptoms, de-
pression, anger, and couples' conflict ratings. The second aim of this
study is to compare results from the B-CBCT-HB and B-CBCT-OB con-
ditions on the same three primary outcomes of PTSD symptoms, cou-
ples’ relationship distress, and functional impairment. We hypothesize
that B-CBCT-HB will be non-significantly different from B-CBCT-OB
(see Fig. 1, Stage 2 tests). The third aim of this study is to compare
engagement and process variables among the three conditions. Our
tertiary hypothesis is that therapy process outcomes, such as enrolment,
therapeutic alliance, and treatment satisfaction, will be significantly
higher in B-CBCT-HB compared to the two office-based conditions, and
dropout will be lower in B-CBCT-HB compared to the two office-based
conditions. We expect the relationship between these process variables
and B-CBCT-HB to be stronger than in the other conditions because
there are fewer barriers and stressors involved in obtaining home-based
treatment (e.g., not needing to travel, wait in a waiting room, co-
ordination of schedules among all parties).
2. Method
2.1. Study design
This randomized controlled trial (RCT) compares B-CBCT delivered
via traditional office-based (B-CBCT-OB) and home-based CVT (B-
CBCT-HB) modalities to an office-based 8-session couple-based psy-
choeducation control condition (PTSD Family Education; PFE; [22]).
The primary analyses compare each B-CBCT modality with the control
Fig. 1. Study design diagram and hypothesis testing algorithm.
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condition: B-CBCT-OB vs. PFE control and B-CBCT-HB vs. PFE control
(Stage 1 analyses in Fig. 1). These comparisons are considered primary
in the sense that establishing superiority of each modality to control is a
necessary condition before consideration of each modality's relation-
ship to each other. Should both B-CBCT modalities be superior to PFE,
the outcomes obtained via the two CBCT modalities will be compared to
determine if they are not statistically different. Progression to Stage 2
testing (comparison of the two CBCT modalities) will occur only if Stage
1 analyses show that both modalities are superior to control; progres-
sion to Stage 3 (future non-inferiority testing between the two B-CBCT
modalities) occurs only if no statistically significant differences are
found in Stage 2.
A dedicated non-inferiority trial comparing B-CBCT-OB to B-CBCT-
HB was ruled out because, at study conception, there was only one RCT
that had established CBCT's superiority over a waiting list condition
[21]. No RCTs had examined the efficacy of CBCT in a veteran popu-
lation or examined a B-CBCT protocol, which is a necessary step for
establishing an acceptable non-inferiority margin (i.e., delta). Results of
this study will guide future B-CBCT non-inferiority studies (Stage 3
analysis in Fig. 1) by formally testing the superiority of B-CBCT to a
control, and by providing an estimate of the observed difference be-
tween B-CBCT delivery modalities (Stage 3).
2.2. Participants and recruitment
Participating couples (N=180) at a US Department of Veterans’
Affairs (VA)-based clinical site in San Diego are randomly assigned to
one of three treatment arms (B-CBCT-OB, B-CBCT-HB or PFE) and as-
sessed at five time points: pre-treatment, mid-treatment, post-treat-
ment, 3-months post-treatment, and 6-months post-treatment. To be
included in the study, dyads must include a veteran (age 18 or older)
with a current PTSD diagnosis according to the Diagnostic and Statistical
Manual of Mental Disorders, fifth edition (DSM-5; [23], with symptoms
present for at least 3 months (to allow for potential natural recovery
assessed by the Clinician-Administered PTSD Scale-5; CAPS-5; [24], and
an intimate partner (age 18 or older, any gender, and any sexual or-
ientation) who is willing to participate in the intervention. If on psy-
chiatric medication, the veteran must be on a stable regimen for at least
2 months. Both members of the couple must be willing to: (1) be ran-
domized to any of the three treatment conditions, (2) have assessment
and treatment sessions audio-recorded, (3) not receive other individual
psychotherapy for PTSD or conjoint psychotherapy during the treat-
ment portion of the study. Exclusion criteria in either member of the
dyad include: (1) current substance use disorder (past 3 months) as
assessed by the Alcohol Use Disorders Identification Test (AUDIT;
Saunders, Aasland, Babor, De la Fuente, & Grant, 1993) and Drug Abuse
Screening Test (DAST [25]; (2) current uncontrolled psychotic disorder;
(3) imminent suicidality or homicidality; (4) any severe cognitive im-
pairment (5) probable partner PTSD (i.e.,≥33 on the PCL-5); or (6) any
perpetration of severe physical or sexual relationship aggression in the
past year, including fear and intimidation (as assessed by the Revised
Conflict Tactics Scale [CTS-2-S [26]], the Extended-Hurt, Insult,
Threaten, Scream [E-HITS [27]], item 6 of the Couple Questionnaire [
[28]], and two items assessing current and past fear and/or intimida-
tion of their partner). Participants who do not meet study criteria are
offered referrals to alternate services, as well as assistance in contacting
the referral sites as needed.
A sample of 180 veterans eligible to receive services from the VA
San Diego Healthcare System (VASDHS) is being recruited through
multiple clinics, including the Family Mental Health Program (FMHP),
the PTSD Clinic, and Primary Care Mental Health Clinic. Participants
are also recruited from other non-VA clinics providing services to ve-
terans, including Department of Defense (DoD) and community agen-
cies (e.g., Vet Centers, university counseling centers), the VA electronic
medical records database, and self-referrals through advertisement,
such as posting materials (e.g., pull-tab flyers) in strategic community
locations.
2.3. Assessment
A brief phone screen is administered to determine preliminary
eligibility at the initial contact with each potential participant.
Individuals are given a comprehensive overview of the study, including
discussing treatment modalities and screening for inclusion/exclusion
criteria. Based on initial eligibility review, both members of the couple
are invited to the VASDHS site to complete informed consent proce-
dures and a baseline assessment interview designed to gather back-
ground information (e.g., trauma history, prior treatment history) and
to screen for psychiatric disorders and intimate partner violence. A
master's or doctoral-level clinician administers the CAPS-5 to the PTSD-
positive screened veteran. All interview assessments are audio-recorded
for fidelity purposes. Couples are assessed at: (1) baseline, (2) midpoint
of treatment, (3) immediately post-treatment, (4) 3-months post-treat-
ment, and (5) 6-months post-treatment. Participants also complete
weekly measures of PTSD severity, relationship satisfaction, and in-
timate partner violence. All assessment sessions are conducted on site at
the VASDHS. A complete list of measures and the assessment schedule
are detailed in Table 1.
To minimize the risk of bias, independent evaluators (IE) blind to
participants’ study condition are trained to administer the CAPS-5 to
fidelity via practice interviews until a minimum interrater reliability
rating of 80% is achieved with the original assessors. CAPS-5 reliability
is monitored through weekly meetings in an ongoing fashion to prevent
drift. A random selection of 15% of all CAPS-5 interviews is being re-
viewed for reliability between assessors. The assessment reliability
monitors assess adherence to overall assessment procedures and scoring
the measure; interrater reliability will be calculated.
2.4. Treatment selection
In-office delivered PFE was chosen as the control intervention for
this study because it is a psychoeducation-oriented, couple intervention
that contains the essential and non-specific elements of psychotherapy
(e.g., therapist interaction, partner-to-veteran interaction), but does not
include specific and active ingredients documented to improve PTSD or
couple functioning (e.g., skills training). Additionally, providing psy-
choeducation, such as PFE, to couples requesting therapy is the stan-
dard of care within the VA system. Furthermore, PFE was recently used
as a comparison condition in a RCT evaluating the Structured Approach
Therapy (SAT) for PTSD intervention [45]. Results showed that, al-
though veterans in both the experimental (SAT) and control (PFE)
groups demonstrated significant reductions in PTSD post-treatment and
at 3-month follow-up, SAT was more efficacious (as evidenced by its
greater rates of improvement). An 8-session version of PFE was selected
to control for time spent in therapy to be comparable with the 8-session
B-CBCT protocol.
3. Treatments
3.1. Brief CBCT-Office-based
CBCT is a manualized couple-based intervention for PTSD designed
to simultaneously reduce PTSD symptoms and to enhance relationship
functioning [10]. The original therapy consists of 15, 75-min sessions
organized into three phases that build upon one another and includes
both in- and out-of-session exercises to increase skill acquisition. Phase
1 (sessions 1–2) focuses on the rationale for the therapy and estab-
lishing safety within the relationship (e.g., recognizing early warning
signs of anger, use of conflict management strategies). Phase 2 (sessions
3–7) focuses on increasing relational satisfaction and undermining
avoidance that maintains PTSD and diminishes relationship satisfac-
tion. Couples develop a list of people, places, situations, and feelings
L.A. Morland, et al. Contemporary Clinical Trials Communications 15 (2019) 100369
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that they avoid as a result of PTSD and begin in vivo approach exercises
that are assigned in a graduated manner. Special attention is paid to the
selection of in vivo approach activities that address behavioral and ex-
periential avoidance, and concurrently double as shared rewarding
activities for the couple. Enhanced dyadic communication is used as an
antidote to PTSD-related emotional numbing and avoidance, as well as
a means of increasing emotional intimacy.
In the original version of CBCT, Phase 3 (sessions 8–15) focuses on
examining beliefs that each member of the couple may hold that con-
tribute to PTSD symptoms and relationship problems, culminating with
a discussion of the potential for benefit-finding and growth and a re-
view of gains made and challenges expected in the future. Given pre-
liminary evidence of the efficacy of phases 1 and 2 of CBCT alone, the
current study modified the original 15-session protocol and developed
an 8-session CBCT protocol (B-CBCT). A brief version of CBCT may help
to increase providers’ uptake of the intervention, decrease dropout, and
increase the reach of the intervention to veterans. The modified inter-
vention includes sessions 1–7 from the original protocol and an addi-
tional session (8) that reviews gains, consolidates skills learned, and
identifies and plans for potential challenges in the future. A structured
training procedure and adherence/competence rating form have been
developed for both B-CBCT conditions based on the updated 8-session
protocol.
3.2. Brief CBCT-Home-based
Home-based CBCT utilizes the same 8-session version of CBCT for
PTSD described above (B-CBCT), with additional considerations given
to the use of technology in the delivery of the intervention. B-CBCT-HB
is delivered to couples via their personal computer or tablet located in a
private, quiet setting within the home or their preferred private loca-
tion. Couples without a video-capable home computer, or one that
cannot be located in a private area of the home, are provided with an
Android-compatible or iOS tablet. Prior to session 1, study staff or VA
computer staff conducts a test call with all couples randomized to re-
ceive home-based therapy. To assure patient confidentiality and HIPAA
compliance, VA-approved CVT software is utilized. The most recent VA
Guidance for Home-Based Telemental Health Standard Operating
Procedures [46] is used in order to best implement CBCT via CVT- HB.
Descriptive data on the type and amount of assistance required for
successful home-based delivery is tracked.
3.3. Office-based PTSD Family Education (PFE)
PFE is a manualized PTSD-focused psychoeducation intervention for
couples consisting of eight 90-min couples’ sessions adapted from the
Support and Family Education (SAFE) program [47] and the Behavioral
Family Therapy (BFT) program [48]. PFE involves educating family
members about trauma and other comorbid conditions using didactics,
discussion, and written materials. Skills training is not included in PFE
and clinicians providing PFE are specifically trained to avoid skills
training and other therapeutic interventions beyond psychoeducation.
A structured training protocol and a rating form have been developed to
assess PFE fidelity and competence.
3.4. Treatment delivery
B-CBCT-OB and PFE are delivered in a traditional office-based set-
ting at the VA; both members of the dyad and the therapist are all
present in the therapist's office. In contrast, B-CBCT-HB is delivered by a
therapist located in a VA office, with the dyad connecting via CVT from
their private location of choice (e.g., their home). In all three condi-
tions, participants receive a complete set of therapy-related materials
during the initial baseline assessment. Participants complete weekly
Table 1
Assessment measures.
Measures Baseline Mid-Txt Post-Txt 3M Post-
Txt
6M Post-
Txt
Veteran Partner Interview (I) or Self-
Report (SR)
Adverse Childhood Experiences (ACE [29]; X X X SR
Alabama Parenting Questionnaire (APQ-9 [30]; X X X X X X X SR
Alcohol Use Disorders Identification Test (AUDIT [31]; X X X SR
Beck Depression Inventory (BDI-II [32]; X X X X X X X SR
Beck Scale for Suicidal Ideation (BSS [33]; X X X X X X SR
Changes in Sexual Functioning Questionnaire-Male/Female Versions
(CSFQ-M/F [34];
X X X X X X X SR
Client Satisfaction Questionnaire-8 (CSQ-8 [35]; X X X SR
Clinical Administered PTSD Scale for DSM-5 (CAPS-5 [24]; X X X X X I
Collateral PTSD Checklist for DSM-5 Last Month (PCL-5 [24]; modified to
have the partner rate the veteran's symptoms
X X X X X X SR
Conflict Tactics Scale-Short Form (CTS-2-S [26]; X X X X X X X I/SR
Couples Satisfaction Index (CSI-32 [36]; X X X X X X X SR
Demographics (developed by study team) X X X I
Drug Abuse Screening Test (DAST-10 [25]; X X X SR
Experiences in Close Relationships-Revised (ECR-R [37]; X X X X X X SR
Insomnia Severity Index (ISI [38]; X X X X X X X SR
Intimate Partner Violence Assessment-Extended (IPV-E [28]; modified by
the study team to include additional items)
X X X SR
Intimate Partner Violence Assessment-Three Items (IPV-3 [28]; X X X X X X I
Intimate Partner Violence Screening Tool-Extended (E-HITS [27]; X X X SR
Inventory of Psychosocial Functioning-Brief (B-IPF [39]; X X X X X X X SR
Life Events Checklist for DSM-5 (LEC-5 [24]; X X X I
Life Events & Treatment Information Questionnaire (LETI; developed by
study team)
X X X X X I
Posttraumatic Cognitions Inventory-9 (PTCI-9; Wells et al., 2017) X X X X X X SR
Posttraumatic Cognitions Inventory-Full (PTCI [40]; X X SR
PRIME Screen-Revised (PS-R [41]; X X X X X X SR
PTSD Checklist for DSM-5 (PCL-5 [24]; X X X X X X X SR/I
Significant Others' Response to Trauma Scale (SORTS [42]; X X X X X SR
State-Trait Anger Expression Inventory-2 (STAXI-2 [43]; X X X X X X X SR
Telehealth Satisfaction [44]; p.7) X X X X X X SR
Treatment Preferences (developed by study team) X X SR
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session assessments prior to meeting with their therapist to track pro-
gress and to assess safety. In the office-based conditions, participants
complete paper-and-pencil versions of the weekly measures, whereas
home-based participants are contacted by study staff via phone im-
mediately prior to logging into the computer for the therapy appoint-
ment to verbally report answers to each self-report questionnaires that
they completed. Weekly scores are tracked and the provider has access
to assessment data prior to the start of the session, regardless of mod-
ality. All treatment sessions across the three conditions are audio-re-
corded for purposes of assessing fidelity and provision of supervision. In
the event of a therapeutic crisis between two sessions (e.g., infidelity,
potential dissolution of the relationship, or other unforeseen event), the
therapist and couple can collaboratively decide to complete an “ASAP”
session to focus on managing the emergent situation. ASAP sessions will
be used sparingly and couples are told that no more than two ASAP
sessions can occur during the course of the 8-session intervention.
Sessions are coded as ASAP sessions, do not replace a manualized ses-
sion, and are not evaluated as part of the fidelity process. Theses ASAP
session will be tracked and reported in the primary outcome paper.
Therapy then resumes the following scheduled session and covers the
content of the next consecutive session.
3.5. Therapist selection
Treatment is provided by clinicians who have a Master's degree or
higher and a minimum of two years of clinical experience. These clin-
icians are trained to administer both B-CBCT and the PFE protocols, and
are assigned to treat couples randomized to each condition in equal
numbers based primarily on couples' and therapists' availability. Each
therapy requires a two-day intensive workshop led by an expert in the
respective treatments. Following the initial workshop, audio-recorded
pilot cases were reviewed by expert trainers to ensure that each therapy
was delivered with adherence and competence to study protocols.
Following completion of pilot cases, therapists who were deemed
qualified to provide the therapies began attending weekly group con-
sultation teleconferences to ensure ongoing fidelity to the treatments.
3.6. Treatment fidelity monitoring
Ongoing close supervision (adherence and competence) is closely
monitored to ensure that the therapy being delivered adheres to the
study protocol. In order to ensure that the treatment is administered in
accordance with the respective treatment manual, all sessions in the
study are recorded for supervision purposes and for possible selection
for fidelity rating. In addition to weekly consultation to assure ongoing
treatment fidelity, 20% of available participant IDs will be randomly
selected for review by CBCT and PFE experts in order to evaluate fi-
delity, with equal numbers of each treatment arm evaluated. In addi-
tion 10% of the recordings selected for treatment fidelity monitoring
will be randomly selected for double rating to determine inter-rater
reliability (kappa) for treatment adherence and competence.
3.7. Planned statistical analyses
3.7.1. Preliminary analyses
Preliminary analyses will examine distributional characteristics of
study variables and provide a description of the study sample and allow
for assessment of randomization. Demographic, baseline clinical char-
acteristics of the individual veteran and/or couple dyad, and other
putative prognostic variables (e.g., diagnostic profile, health func-
tioning) will be compared for imbalance across the treatment groups
using analysis of variance (or a nonparametric equivalent) for con-
tinuous variables and chi-square tests for categorical variables. If, de-
spite randomization, significant group differences at baseline are
identified, those variables will be included as covariates in subsequent
analyses.
3.7.2. Power analysis
The primary comparisons in which each active treatment is com-
pared to control involve directional hypotheses with two multiple
comparisons (CBCT-OB superior to PFE, CBCT-HB superior to PFE).
Assuming four post-randomization measurement time points, level of
significance α=0.05, one-tailed comparison adjusted for multiple
comparisons, correlation between pairs of measurements within parti-
cipants (interclass correlation) no larger than ρ=0.5, we estimated
that with 48 couples per group (total n= 144), we will have 80%–85%
power to detect a standardized effect size of 0.45–0.48 SD (i.e., Cohen's
d effect size measured in units of standard deviation). Based on data
from our previous studies with similar populations, we estimate the SD
of CAPS scores to be 20, yielding a CAPS raw score intervention dif-
ference that can be detected of 9.0–9.7 units for individual veteran
analyses and 7.6–8.1 for couple-based analyses. The IPF total and scale
scores also have SD of approximately 20, yielding same power estimates
as for CAPS scores. To compare relationship distress outcomes for the
dyad, we estimate 80%–85% power to detect a 0.38–0.41 SD difference
between active treatment and control group means. The final sample
size estimate was inflated by 20%–180 couples (60 per group) to ac-
count for the attrition and the dilution effect of ITT analyses.
3.7.2.1. Analyses for efficacy outcomes (Hypothesis 1). Longitudinal
trajectories of outcomes from baseline to mid-treatment, post-
treatment, 3-month, and 6-monh follow-up time points will be
compared using multivariable, multilevel generalized linear mixed
models (GLMM), which accommodate a wide range of distributional
assumptions, including continuous, categorical/dichotomous, ordinal,
and count predictors. In addition, GLMM allow for missing and
multilevel data, such as possible cluster effects due to correlations
among repeated measures, correlation within couples, and correlation
between participants within therapists, through inclusion of random
effects in the model [49].
The primary efficacy outcome variables are: (1) clinician-rated
PTSD symptoms (CAPS-5 severity scores), (2) relationship distress (CSI;
[36], and (3) functional impairment (B-IPF; [39]. Secondary variables
include PTSD diagnostic status (CAPS-5), self-reported PTSD symptoms
(PCL-5; Blake et al., 2013), depression scores (BDI-II; [32], anger
(STAXI-2; [43], and relationship conflict (CTS-2-S; [26]. Each of the
primary and secondary outcome measures will be examined separately
in a series of multilevel models. Each model will examine the predictive
value of the primary variable of interest: (1) time (fixed effects), (2)
treatment group (fixed effects), and (3) the cross-level interaction of
time*treatment group (fixed effects). Baseline scores on the dependent
measure will also be included as a model covariate, to control for their
effect. For couple-based outcomes (e.g., CSI scores), between-dyad,
within-dyad, and mixed variables will be coded in the model as de-
scribed by Ref. [50].
For Stage 1 analyses addressing the primary hypothesis, pairwise
unadjusted (or covariate-adjusted, if necessary) differences in least
squares means for each outcome variable will be compared at mid-
treatment, post-treatment, and at the 3- and 6-month follow-up time
points using appropriate model contrasts (i.e., CBCT-OB vs. PFE and
CBCT-HB vs. PFE). Next, in Stage 2 analyses addressing the secondary
hypothesis (), unadjusted and least squares adjusted means from the
GLMM contrast comparisons, along with corresponding 95% CIs, will
provide estimates of the magnitude (effect sizes), direction, and sta-
tistical significance of differences in outcome measures for CBCT-OB
compared to CBCT-HB. Progression to a future fully powered non-in-
feriority trial (Stage 3, Fig. 1) occurs only if both CBCT delivery mod-
alities are superior to the control intervention. In that event, this study
provides necessary input information (e.g., variance-covariance and
effect size estimates) for the design of the subsequent non-inferiority
study. If only one CBCT delivery modality is superior to the control
intervention, then the additional test for non-superiority between CBCT
arms is not required (see Fig. 1 for additional information). While the
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study chose three primary outcome measures (i.e., CAPS-5, CSI and B-
IPF scores), if there are mixed findings regarding the superiority of the
CBCT conditions compared to PFE, the results from based on the CAPS-
5 scores will be more heavily weighted in decision-making as the pri-
mary focus of the treatment is towards reducing posttraumatic symp-
toms. To address possible Type I errors due to multiple dependent
variables, we specify a priori the primary measures corresponding to the
stated a priori hypotheses within the following specified domains: PTSD
symptoms, relationship satisfaction and functional impairment.
3.7.2.2. Primary analyses for process outcomes. To address tertiary
hypotheses, measures of treatment process outcomes include ease of
treatment delivery (as rated by participants and therapists), treatment
satisfaction (as measured by the Couples Satisfaction Questionnaire,
CSQ), therapeutic alliance (for both participants' and therapists’
Working Alliance Inventory, WAI), safety issues (tracked by clinical
team) and general program management issues tracked by the
coordinator. Additional measures of feasibility are recruitment
(percentage who agree to participate out of number approached),
compliance (percentage of session attended, percentage of homework
assignments completed), and retention (dropout rate). GLMM will be
used to compare the feasibility outcomes between each of the two CBCT
delivery modalities at the post-treatment time point. The longitudinal
profile of adherence as a dichotomous outcome at each visit (e.g.,
attended/did not attend a given session) within the active intervention
period will also be modeled using GLMM. Ninety-five percent CIs for
proportions (within groups) and differences in proportions (between
groups) obtained from the GLMM analyses will be used to estimate the
dichotomous feasibility outcomes (e.g., proportion of couples who
participate to number approached; proportion of couples who
dropped out to number who complete treatment). Ninety-five percent
CIs on means and differences in means will be used to describe
continuous feasibility outcomes. Frequency distributions describing
the reasons for noncompliance and discontinuation of study
participation will be developed. For secondary analyses using
additional outcome variables within a given domain, we will report
both unadjusted p-values and adjusted p-values using a Tukey-type
correction for multiple outcomes. Further, secondary outcomes and
exploratory analyses will be evaluated qualitatively in terms of
consistency with primary results and conservatively in terms of
statistical significance of results. Sensitivity of study results to
adjustment for multiplicity of outcomes will be evaluated.
4. Discussion
This RCT examines the efficacy of an abbreviated couple interven-
tion for PTSD (B-CBCT) delivered in-office versus through a home-
based CVT modality against an in-office delivered, psychoeducation-
focused active control condition (PFE). It offers several innovations,
including the testing of a briefer version of CBCT that is more scalable,
the use of strong methodology to examine the efficacy of the CVT
modality to deliver couple therapy, and the use of functioning as one of
the primary outcomes. The findings of this study could have a major
impact on the delivery of PTSD services within the VA system and in the
public sector, where brief evidence-based treatments that incorporate
family are hard to access.
The study is particularly novel for several reasons. First, the study
was developed specifically to address the barriers to treatment en-
gagement and retention that veterans frequently face when trying to
obtain psychological care for PTSD. Based on recent research suggesting
many veterans are only receiving the first two phases of CBCT in the
VA's dissemination project, and large effect sizes for the first two phases
of treatment, study staff conducted an evidence-based adaptation and
shortened the length of the CBCT protocol - from 15 to 8 sessions - in
order to provide a more feasible and practical intervention that may be
more appealing to veterans and their partners, as well as more cost-
effective.
Second, this study is one of the first to conduct an RCT to examine
the efficacy of couple therapy delivered through the CVT modality.
Although the efficacy of the CVT modality has been established across a
variety of different treatments [51], the vast majority of research on
CVT is on individual therapy delivered via office-based CVT; almost no
research has been done on the efficacy of couple therapy when deliv-
ered via telehealth, particularly home-based telehealth. Although of-
fice-based CVT allows veterans to obtain care from their local VA fa-
cilities rather than having to travel to a larger hospital, even travel to a
local clinic can require significant travel and result in a number of other
barriers to care. Veterans are interested in flexible, home-based care
with lower travel and time burden [52], and this study examines the
efficacy of the couple's intervention delivered via home-based CVT as
the dyad remains remain in the comfort and privacy of their own home
to receive treatment. The described study will also explore the feasi-
bility and efficacy of the CVT modality's use within the veteran's home,
which could reduce travel time and cost to clinics. Further, home-based
CVT and the inclusion of a partner in therapy may increase treatment
retention and engagement. Findings of this study may establish the
clinical utility and efficacy of providing couple-based counseling for
PTSD through CVT to veterans and their partners.
Finally, most PTSD treatment studies focus on symptom improve-
ment as the primary outcome metric. However, it is also critically im-
portant to examine domains related to life functioning, in addition to
symptom improvements, in order to better assess the multidimensional
impact of psychosocial interventions. This study incorporates a multi-
domain assessment protocol that includes measures of psychological
health and psychosocial functioning, and relationship functioning in
particular. Although the relationship between PTSD and reduced
functioning has long been established [53], the impact of PTSD treat-
ments on quality of life and psychosocial functioning has received far
less attention [21,53]; Schnurr et al., 2016; [54]. This study will offer a
comprehensive evaluation of the effects of CBCT treatment among ve-
terans with PTSD and their partners across several different domains.
In addition to its novelty, this study has several important strengths
that will enhance the impact of the study findings. The study metho-
dology incorporates a control condition (PFE) that will allow for the
evaluation of the active components of B-CBCT in comparison to gen-
eral couple-focused contact and PTSD education. Furthermore, the
study is a highly controlled RCT that will allow for testing the efficacy
of the brief CBCT protocol and the use of the CVT delivery modality.
This well-controlled design will also provide the opportunity to conduct
future non-inferiority analyses should the first two aims suggest that
there are no significant differences between CVT and in-person treat-
ment modalities. The use of staged analysis within the study data plan
will serve to maximize data utility and the impact of the findings.
Overall, our phased study design will allow us to address multiple re-
search questions within the same study protocol, establishing a novel
time- and cost-effective method of conducting treatment outcome re-
search.
Importantly, these study findings will have direct implications for
the treatment of PTSD within healthcare systems. Results will expand
the current research on CBCT with respect to its clinical effectiveness.
Currently, the VA and the community more generally offers few evi-
dence-based interventions for couple therapy, especially those that
target specific clinical symptoms (e.g., PTSD) rather than general re-
lationship functioning. Further examination of the efficacy of CBCT,
especially in a shorter, more scalable format, may result in a more
expedient adoption of the protocol. This would allow those affected by
PTSD to choose this type of therapy should they be interested in a re-
latively brief intervention for PTSD that includes their partner. This
study may also establish the efficacy of a home-based service delivery
option and provide information on the feasibility and protocol mod-
ifications required for delivering a couple-based intervention over
home-based CVT. We hope this information will inform future training
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and policy decisions. Indeed, this project will be a necessary first step
towards broad clinical implementation of evidence-based PTSD couples
services, particularly in the home setting via CVT.
There is a broader public health need for brief, highly accessible
mental health interventions that are effective and easily implemented
throughout different healthcare systems. Individuals with PTSD and
their loved ones encounter real-life barriers that prevent them from
accessing or fully benefiting from evidence-based interventions. Brief
psychological treatments offered in-home via technology may en-
courage more individuals to seek out, and engage in, mental health
services. This may be particularly important for those who live in rural
communities, as home-based telehealth provides an opportunity to re-
duce health care disparities among individuals who are most impacted
by barriers to receiving high-quality mental health treatment.
Examining and incorporating technology into the mental health system
is a public health issue, as the impact of these initiatives will affect all
consumers of psychological treatment.
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